Results 231 to 240 of about 39,918 (251)

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial

Circulation, 2022
Sean D Pokorney, Hussein R Al-Khalidi, Renato Delascio Lopes   +2 more
exaly  

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Journal of Thrombosis and Haemostasis, 2020
Waldemar E Wysokinski, Jennifer G Le-Rademacher, Aneel A Ashrani   +2 more
exaly  

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

New England Journal of Medicine, 2020
Giancarlo Agnelli, Cecilia Becattini, Menno V Huisman   +2 more
exaly  

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine, 2011
Christopher B Granger, John H Alexander, John J V Mcmurray   +2 more
exaly  

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Lancet, The, 2010
Alexander S Gallus
exaly  

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

Circulation, 2020
John W Stanifer, Glenn Chertow, Samira Garonzik   +2 more
exaly  

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

New England Journal of Medicine, 2013
Giancarlo Agnelli, Alexander T Cohen, Alexander S Gallus   +2 more
exaly  

Apixaban in Patients with Atrial Fibrillation

New England Journal of Medicine, 2011
Stuart J Connolly, John W. Eikelboom, Sergey Golitsyn   +2 more
exaly  

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

Lancet Neurology, The, 2012
J Donald Easton, M Cecilia Bahit, Christopher B Granger   +2 more
exaly